• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SUMO化修饰调控孕激素受体转录活性的潜在机制。

Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation.

作者信息

Abdel-Hafiz Hany, Dudevoir Michelle L, Horwitz Kathryn B

机构信息

Department of Medicine, Division of Endocrinology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado 80045, USA.

出版信息

J Biol Chem. 2009 Apr 3;284(14):9099-108. doi: 10.1074/jbc.M805226200. Epub 2009 Feb 11.

DOI:10.1074/jbc.M805226200
PMID:19211567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2666559/
Abstract

Posttranslational modification by small ubiquitin-like modifier (SUMO) is a major regulator of transcription. We previously showed that progesterone receptors (PR) have a single consensus psiKXE SUMO-conjugation motif centered at Lys-388 in the N-terminal domain of PR-B and a homologous site of PR-A. SUMOylation of the PR is hormone-dependent and has a suppressive effect on transcription of an exogenous promoter. Here we show that repression of PR activity by SUMOylation at Lys-388 is uncoupled from phosphorylation, involves synergy between tandem progesterone response elements, and is associated with lowered ligand sensitivity and slowed ligand-dependent down-regulation. However, paradoxically, cellular overexpression of SUMO-1 increases PR transcriptional activity even if Lys-388 is mutated, suggesting that the receptors are activated indirectly by other SUMOylated proteins. One of these is the coactivator SRC-1, whose binding to PR and enhancement of agonist-dependent N-/C-terminal interactions is augmented by the presence of SUMO-1. Increased transcription due to SRC-1 is independent of PR SUMOylation based on assays with the Lys-388 mutants and the pure antiprogestin ZK98299, which blocks N-/C-terminal interactions. In summary, SUMOylation tightly regulates the transcriptional activity of PR by repressing the receptors directly while activating them indirectly through augmented SRC-1 coactivation.

摘要

小泛素样修饰物(SUMO)介导的翻译后修饰是转录的主要调节方式。我们之前发现,孕激素受体(PR)在PR-B的N端结构域中存在一个位于赖氨酸-388的单一共有psiKXE SUMO结合基序,PR-A也有一个同源位点。PR的SUMO化修饰是激素依赖性的,对外源启动子的转录具有抑制作用。在此我们发现,赖氨酸-388位点的SUMO化对PR活性的抑制作用与磷酸化无关,涉及串联孕激素反应元件之间的协同作用,并且与配体敏感性降低和配体依赖性下调减慢有关。然而,矛盾的是,即使赖氨酸-388发生突变,细胞中SUMO-1的过表达仍会增加PR的转录活性,这表明受体是被其他SUMO化蛋白间接激活的。其中之一是共激活因子SRC-1,SUMO-1的存在增强了它与PR的结合以及对激动剂依赖性N端/C端相互作用的增强作用。基于对赖氨酸-388突变体和纯抗孕激素ZK98299的检测,由于SRC-1导致的转录增加与PR的SUMO化无关,ZK98299可阻断N端/C端相互作用。总之,SUMO化通过直接抑制受体,同时通过增强SRC-1共激活间接激活受体,从而严格调控PR的转录活性。

相似文献

1
Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation.SUMO化修饰调控孕激素受体转录活性的潜在机制。
J Biol Chem. 2009 Apr 3;284(14):9099-108. doi: 10.1074/jbc.M805226200. Epub 2009 Feb 11.
2
Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation.通过 SUMOylation 和 deSUMOylation 控制孕激素受体转录协同作用。
BMC Mol Biol. 2012 Mar 22;13:10. doi: 10.1186/1471-2199-13-10.
3
Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1.孕酮受体和类固醇受体辅激活因子SRC-1的类泛素化修饰。
J Biol Chem. 2003 Apr 4;278(14):12335-43. doi: 10.1074/jbc.M207148200. Epub 2003 Jan 14.
4
Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.磷酸化依赖性的SUMO化拮抗作用可解除乳腺癌细胞中孕激素受体的抑制作用。
Mol Endocrinol. 2007 Dec;21(12):2890-906. doi: 10.1210/me.2007-0248. Epub 2007 Aug 23.
5
Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription.组蛋白乙酰转移酶与ORC-1结合(HBO1)与孕激素受体N端反式激活结构域的配体控制相互作用诱导类固醇受体辅激活因子1依赖的转录共激活。
Mol Endocrinol. 2006 Sep;20(9):2122-40. doi: 10.1210/me.2005-0149. Epub 2006 Apr 27.
6
Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.磷酸化和 sumoylation 缺陷的孕激素受体在乳腺癌进展过程中驱动增殖性基因特征。
Breast Cancer Res. 2012 Jun 14;14(3):R95. doi: 10.1186/bcr3211.
7
Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B.孕激素受体(PR)-B和-A通过不同机制调节转录:AF-3对共激活因子与PR-B的结合发挥调控作用。
Mol Endocrinol. 2006 Nov;20(11):2656-70. doi: 10.1210/me.2006-0105. Epub 2006 Jun 8.
8
Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.小泛素样修饰物1(SUMO-1)对腺病毒4结合蛋白/类固醇生成因子1(Ad4BP/SF-1)协同控制基序的修饰作用,可调节Ad4BP/SF-1与Sox9之间的协同转录。
Mol Endocrinol. 2004 Oct;18(10):2451-62. doi: 10.1210/me.2004-0173. Epub 2004 Jun 10.
9
Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.蛋白激酶介导乳腺癌细胞中经SUMO化修饰的孕激素受体的非配体依赖性去抑制。
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14287-92. doi: 10.1073/pnas.0905118106. Epub 2009 Aug 17.
10
Sumoylated SnoN represses transcription in a promoter-specific manner.SUMO化修饰的SnoN以启动子特异性方式抑制转录。
J Biol Chem. 2006 Nov 3;281(44):33008-18. doi: 10.1074/jbc.M604380200. Epub 2006 Sep 11.

引用本文的文献

1
The transcriptional activity of progestins used in contraception and menopausal hormone therapy via progesterone receptor A is dependent on the density of the receptor.避孕药和绝经激素治疗中使用的孕激素通过孕激素受体 A 的转录活性取决于受体的密度。
Biochem Biophys Res Commun. 2023 Jan 8;639:70-76. doi: 10.1016/j.bbrc.2022.11.077. Epub 2022 Nov 26.
2
Progesterone Receptor Signaling in the Uterus Is Essential for Pregnancy Success.孕激素受体信号在子宫内对于妊娠成功至关重要。
Cells. 2022 Apr 27;11(9):1474. doi: 10.3390/cells11091474.
3
Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptor.孕激素受体介导的激素避孕药物及孕激素的特征化
Biochem Biophys Res Commun. 2020 Dec 17;533(4):879-885. doi: 10.1016/j.bbrc.2020.09.058. Epub 2020 Sep 29.
4
FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors - implications for therapy of luminal breast cancer.成纤维细胞生长因子(FGFs)/成纤维细胞生长因子受体(FGFRs)依赖性信号通路在调节甾体激素受体中的作用——对腔面乳腺癌治疗的启示。
J Exp Clin Cancer Res. 2019 May 29;38(1):230. doi: 10.1186/s13046-019-1236-6.
5
An Approach to Greater Specificity for Glucocorticoids.提高糖皮质激素特异性的方法。
Front Endocrinol (Lausanne). 2018 Mar 13;9:76. doi: 10.3389/fendo.2018.00076. eCollection 2018.
6
SUMOylation Regulates Transcription by the Progesterone Receptor A Isoform in a Target Gene Selective Manner.SUMO化以靶基因选择性方式调控孕酮受体A亚型的转录。
Diseases. 2018 Jan 2;6(1):5. doi: 10.3390/diseases6010005.
7
The transcriptional repressor GATAD2B mediates progesterone receptor suppression of myometrial contractile gene expression.转录抑制因子GATAD2B介导孕激素受体对子宫肌层收缩基因表达的抑制作用。
J Biol Chem. 2017 Jul 28;292(30):12560-12576. doi: 10.1074/jbc.M117.791350. Epub 2017 Jun 2.
8
Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.活性FOXO1是亚型特异性孕激素受体反式激活和衰老编程的关键决定因素。
Mol Cancer Res. 2016 Feb;14(2):141-62. doi: 10.1158/1541-7786.MCR-15-0431. Epub 2015 Nov 17.
9
Progesterone action in breast, uterine, and ovarian cancers.孕酮在乳腺癌、子宫癌和卵巢癌中的作用。
J Mol Endocrinol. 2015 Apr;54(2):R31-53. doi: 10.1530/JME-14-0252. Epub 2015 Jan 13.
10
Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus.孕激素受体信号在妊娠启动及健康子宫维持中的作用
Int J Dev Biol. 2014;58(2-4):95-106. doi: 10.1387/ijdb.140069mw.

本文引用的文献

1
SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.小泛素样修饰蛋白介导的糖皮质激素受体协同活性抑制作用取决于在启动子处的稳定组装,而非取决于死亡结构域相关蛋白。
Mol Endocrinol. 2008 Sep;22(9):2061-75. doi: 10.1210/me.2007-0581. Epub 2008 Jun 18.
2
Progesterone receptor isoforms in normal and malignant breast.正常和恶性乳腺组织中的孕激素受体亚型
Ernst Schering Found Symp Proc. 2007(1):77-107.
3
Progesterone induction of the 11beta-hydroxysteroid dehydrogenase type 2 promoter in breast cancer cells involves coordinated recruitment of STAT5A and progesterone receptor to a distal enhancer and polymerase tracking.孕激素诱导乳腺癌细胞中2型11β-羟类固醇脱氢酶启动子的过程涉及信号转导和转录激活因子5A(STAT5A)与孕激素受体协同募集至一个远端增强子以及聚合酶追踪。
Mol Cell Biol. 2008 Jun;28(11):3830-49. doi: 10.1128/MCB.01217-07. Epub 2008 Mar 31.
4
SUMO: getting it on.小泛素样修饰蛋白:开始作用。
Biochem Soc Trans. 2007 Dec;35(Pt 6):1409-13. doi: 10.1042/BST0351409.
5
Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.磷酸化依赖性的SUMO化拮抗作用可解除乳腺癌细胞中孕激素受体的抑制作用。
Mol Endocrinol. 2007 Dec;21(12):2890-906. doi: 10.1210/me.2007-0248. Epub 2007 Aug 23.
6
Amino-terminal domain of TIF2 is involved in competing for corepressor binding to glucocorticoid and progesterone receptors.转录中介因子2(TIF2)的氨基末端结构域参与竞争共抑制因子与糖皮质激素受体和孕激素受体的结合。
Biochemistry. 2007 Jul 10;46(27):8036-49. doi: 10.1021/bi7004575. Epub 2007 Jun 16.
7
SUMO and NF-kappaB ties.小泛素样修饰蛋白与核因子κB的关系
Cell Mol Life Sci. 2007 Aug;64(15):1979-96. doi: 10.1007/s00018-007-7005-2.
8
Regulation of SRC family coactivators by post-translational modifications.通过翻译后修饰对SRC家族共激活因子的调控。
Cell Signal. 2007 Jun;19(6):1101-12. doi: 10.1016/j.cellsig.2007.02.002. Epub 2007 Feb 20.
9
A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator.阿索普瑞尼尔的结构与体外特性:一种选择性孕激素受体调节剂
Mol Endocrinol. 2007 May;21(5):1066-81. doi: 10.1210/me.2006-0524. Epub 2007 Mar 13.
10
CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.含CUE结构域蛋白2通过泛素-蛋白酶体途径调控孕激素受体的降解。
EMBO J. 2007 Apr 4;26(7):1831-42. doi: 10.1038/sj.emboj.7601602. Epub 2007 Mar 8.